Seuraa
Tanya Golubchik
Tanya Golubchik
Sydney Institute for Infectious Diseases, School of Medical Sciences, University of Sydney
Vahvistettu sähköpostiosoite verkkotunnuksessa sydney.edu.au - Kotisivu
Nimike
Viittaukset
Viittaukset
Vuosi
Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity
E Volz, V Hill, JT McCrone, A Price, D Jorgensen, Á O’Toole, J Southgate, ...
Cell 184 (1), 64-75. e11, 2021
11692021
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort study
KA Twohig, T Nyberg, A Zaidi, S Thelwall, MA Sinnathamby, S Aliabadi, ...
The Lancet Infectious Diseases 22 (1), 35-42, 2022
9372022
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B. 1.1. 7): an exploratory analysis of a randomised controlled trial
KRW Emary, T Golubchik, PK Aley, CV Ariani, B Angus, S Bibi, B Blane, ...
The Lancet 397 (10282), 1351-1362, 2021
7702021
Diverse Sources of C. difficile Infection Identified on Whole-Genome Sequencing
DW Eyre, ML Cule, DJ Wilson, D Griffiths, A Vaughan, L O'Connor, CLC Ip, ...
New England Journal of Medicine 369 (13), 1195-1205, 2013
7592013
Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis
P Bradley, NC Gordon, TM Walker, L Dunn, S Heys, B Huang, S Earle, ...
Nature communications 6 (1), 10063, 2015
6362015
Multilocus Sequence Typing of Clostridium difficile
D Griffiths, W Fawley, M Kachrimanidou, R Bowden, DW Crook, R Fung, ...
Journal of clinical microbiology 48 (3), 770-778, 2010
5112010
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7
B Meng, SA Kemp, G Papa, R Datir, IATM Ferreira, S Marelli, WT Harvey, ...
Cell reports 35 (13), 2021
4792021
SARS-CoV-2 within-host diversity and transmission
KA Lythgoe, M Hall, L Ferretti, M de Cesare, G MacIntyre-Cockett, ...
Science 372 (6539), 2021
405*2021
Prediction of Staphylococcus aureus antimicrobial resistance by whole-genome sequencing
NC Gordon, JR Price, K Cole, R Everitt, M Morgan, J Finney, AM Kearns, ...
Journal of clinical microbiology 52 (4), 1182-1191, 2014
3922014
Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study
MS Graham, CH Sudre, A May, M Antonelli, B Murray, T Varsavsky, ...
The Lancet Public Health 6 (5), e335-e345, 2021
3652021
Prediction of susceptibility to first-line tuberculosis drugs by DNA sequencing
CRyPTIC Consortium and the 100,000 Genomes Project
New England Journal of Medicine 379 (15), 1403-1415, 2018
3602018
Effects of control interventions on Clostridium difficile infection in England: an observational study
KE Dingle, X Didelot, TP Quan, DW Eyre, N Stoesser, T Golubchik, ...
The Lancet Infectious Diseases 17 (4), 411-421, 2017
3312017
Evolutionary dynamics of Staphylococcus aureus during progression from carriage to disease
BC Young, T Golubchik, EM Batty, R Fung, H Larner-Svensson, ...
Proceedings of the National Academy of Sciences 109 (12), 4550-4555, 2012
3302012
A pilot study of rapid benchtop sequencing of Staphylococcus aureus and Clostridium difficile for outbreak detection and surveillance
DW Eyre, T Golubchik, NC Gordon, R Bowden, P Piazza, EM Batty, ...
BMJ open 2 (3), e001124, 2012
3032012
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020
E Alm, EK Broberg, T Connor, EB Hodcroft, AB Komissarov, ...
Eurosurveillance 25 (32), 2001410, 2020
2692020
Assessment of Mycobacterium tuberculosis transmission in Oxfordshire, UK, 2007–12, with whole pathogen genome sequences: an observational study
TM Walker, MK Lalor, A Broda, LS Ortega, M Morgan, L Parker, ...
The Lancet Respiratory Medicine 2 (4), 285-292, 2014
2512014
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
COMBATC Consortium
Cell 185 (5), 916-938.e58, 2022
2422022
Within-host evolution of Staphylococcus aureus during asymptomatic carriage
T Golubchik, EM Batty, RR Miller, H Farr, BC Young, H Larner-Svensson, ...
PloS one 8 (5), e61319, 2013
2422013
Microevolutionary analysis of Clostridium difficile genomes to investigate transmission
X Didelot, DW Eyre, M Cule, CLC Ip, MA Ansari, D Griffiths, A Vaughan, ...
Genome biology 13, 1-13, 2012
2382012
Evolutionary History of the Clostridium difficile Pathogenicity Locus
KE Dingle, B Elliott, E Robinson, D Griffiths, DW Eyre, N Stoesser, ...
Genome biology and evolution 6 (1), 36-52, 2014
2022014
Järjestelmä ei voi suorittaa toimenpidettä nyt. Yritä myöhemmin uudelleen.
Artikkelit 1–20